52Q fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Magnasense AB engages in the development and commercialization of drug monitoring tests. Its products include Viraspec COVID-19 Saliva Test and moNATor. The company was founded on September 26, 2019 and is headquartered in Lund, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
52Q does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company